← Back to headlines
BridgeBio Pharma Achieves Record 2025 Revenue
BridgeBio Pharma reported record revenue for 2025, largely due to the commercial success of its drug Attruby.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
US Army Awards $2.2 Billion for Nuclear Microreactors at Five Bases
15m ago
Oil Prices Decline on Prospects of Diplomatic Talks to Ease Middle East Supply Disruptions
36m ago
FSSAI Issues Food Safety Notices to Premier Delhi Hotels Ahead of BRICS Summit
53m ago
South Korea Central Bank Raises Rates to 3%, Upgrades Growth Forecast
54m ago